Schedule 13G ownership disclosure

Fate Therapeutics Inc

Security class unavailable · CUSIP: 31189P102

Event date: 2023-03-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001273087-23-000102
Form type
SC 13G
Filer
FATE THERAPEUTICS INC
CIK
CIK 1434316
Filed
Mar 22, 2023
Reporting period
Mar 16, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub